CDNA Stock Summary and Trading Ideas (Caredx | NASDAQ:CDNA)

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Caredx trades on the NASDAQ stock market under the symbol CDNA.

As of February 20, 2026, CDNA stock price declined to $18.80 with 414,991 million shares trading.

CDNA has a beta of 0.70, meaning it tends to be less sensitive to market movements. CDNA has a correlation of 0.03 to the broad based SPY ETF.

CDNA has a market cap of $1.00 billion. This is considered a Small Cap stock.

Last quarter Caredx reported $100 million in Revenue and $.28 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.24.

In the last 3 years, CDNA traded as high as $34.84 and as low as $4.80.

The top ETF exchange traded funds that CDNA belongs to (by Net Assets): ARKG, VTI, XBI, IWM, VXF.

CDNA has underperformed the market in the last year with a price return of -19.6% while the SPY ETF gained +14.1%. However, in the short term, CDNA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.3% vs +6.0% return in SPY. But in the last 2 weeks, CDNA shares have been beat by the market, returning -3.4% compared to an SPY return of -0.2%.

CDNA support price is $19.15 and resistance is $20.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CDNA shares will trade within this expected range on the day.